Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRBP
DataHoraFonteTítuloCódigoCompanhia
09/05/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/05/202417:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/05/202417:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202419:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202419:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202418:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202418:41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202419:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/01/202411:16Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202409:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202307:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
13/06/202317:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/06/202317:54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/06/202307:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/05/202317:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
19/05/202310:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/05/202318:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202317:32Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202317:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
10/03/202318:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202318:30Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202312:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
15/02/202308:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/11/202219:51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/11/202208:25TipRanksCorbus Pharmaceuticals (CRBP) Gets a Buy from H.C. WainwrightNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/10/202209:05PR Newswire (US)Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/10/202218:09Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
26/09/202209:05PR Newswire (US)Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/09/202209:00PR Newswire (US)Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/09/202208:00PR Newswire (US)Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRBP